Tenascin C, undulin, collagen XIV and ®bronectin are extracellular matrix glycoproteins with a partial DNA sequence homology. During embryogenesis, tenascin C is abundant in mesenchymal tissues but its distribution in human adult tissue is severely restricted. The levels of tenascin C expression are enhanced with skin in¯ammation, wound healing and hyperproliferative skin diseases and return to normal in normal scar tissue after wound contraction is completed. Undulin/collagen XIV is associated with collagen ®brils and ®bronectin is present throughout the dermis in adult skin but it is produced by keloidal ®broblasts in an increased amount. In this study we investigated by immunohistochemistry the expression of the three extracellular matrix proteins in keloids and normal skin as well as in keloidal and normal ®broblasts in vitro. In keloids, increased tenascin C expression was observed especially in the reticular dermis associated with collagen ®brils sharply demarcating the limit of the lesion. In normal tissue, tenascin C was only expressed beneath the basal lamina and dermal±epidermal junction. Corresponding to the in vivo ®ndings, tenascin C expression was increased in keloidal ®broblasts compared with normal ®broblasts in vitro (P < 0´003), whereas undulin/collagen XIV and ®bronectin expression in keloids and keloidal ®broblasts was similar to that in normal tissue and normal ®broblasts, respectively. Therefore, tenascin C is a marker associated with keloids and we suggest that keloidal ®broblasts, once stimulated, continue to produce tenascin C independently from circulating factors.
Keloids are characterized by abundant dense ®brotic tissue developing due to abnormal wound healing after skin injury. The mechanism of keloid formation is still unknown. 1, 2 Clinically, keloids extend beyond the con®nes of the original wound, do not regress spontaneously and tend to recur after excision. 1, 3 Histologically, they consist of excessive amounts of thick, densely packed eosinophilic collagen bundles in a focal or irregular pattern with only a few ®bro-blasts and often a mucoid glycosaminoglycan-rich matrix in between. 4, 5 Furthermore, appendages are missing, the epidermis seems to be thin and the papillary structures nearly disappear with effacement of the usually clear borders between the keloid and the reticular dermis. 5, 6 Keloids are rich in extracellular matrix components, especially ®brillar collagen, 7±9 paralleled by elevated levels of ®brogenic cytokines, such as transforming growth factor (TGF)-b1. 10 TGF-b1 has been shown to enhance the expression of several collagen types, ®bronectin and tenascin C in cultured ®broblasts.
10±12
In view of its expression in proliferating and activated extracellular matrices, 13±16 tenascin C could be an interesting molecular marker associated with keloids. Tenascin C and the collagen ®bril-associated new extracellular matrix protein undulin/collagen type XIV (C XIV), which is found in differentiated, quiescent matrices, exhibit complementary patterns of expression. 17, 18 As the expression patterns of tenascin C and C XIV in keloids are not known, we studied the immunohistochemical distribution and the expression by cultured ®broblasts of these molecules and compared them with those of ®bronectin for which a strong expression in keloids has been shown. in sex (three men, one woman) and localization (earlobe, breast and back) were examined immunohistochemically. Keloids had developed after injury: ear piercing (two), surgical excision (one) and scarring acne (one). Primary ®broblast cultures were established from nine keloids (six men, three women; duration of disease 1±7 years) and ®ve normal skin specimens (two men, three women) comparable in age (15±58 years) and localization (earlobe, breast, shoulder and back). Three of ®ve normal skin specimens originated from patients with keloids included in the study. Tissue specimens were snap-frozen in liquid nitrogen and stored at À 80 8C until use. Five-micrometre serial sections were placed on poly-L-lysine solution-coated slides, air-dried and stored in sealed boxes at ± 20 8C for no longer than 14 days. Before use, the sections were thawed slowly and ®xed in acetone at 4 8C for 10 min.
Fibroblast cultures
Primary ®broblast cultures from keloids and normal skin were grown from fresh dermal tissue specimens left to attach on culture dishes (Falcon, Franklin Lakes, NJ, U.S.A.) for about 2 weeks. Tissue and cell cultures were maintained in Dulbecco's minimal essential medium (Seromed-Biochrom, Berlin, Germany) supplemented with 5% fetal calf serum and antibiotics. The cultures were subjected to immunocytological investigations in passages 3±4: 2´10 3 cells were seeded in each well of modi®ed eight-chamber culture vessels (Nunc, Wiesbaden, Germany) maintained in 300 mL culture medium and left to grow until subcon¯uency for 4 days at 37 8C under 5% CO 2 . The slides were then separated from the culture vessels, carefully washed with phosphate-buffered saline (PBS) without Ca 2 and Mg 2 , air-dried and stored in sealed boxes at ± 20 8C for up to 14 days. Before use, the slides were thawed slowly, ®xed in 1% glutaraldehyde solution for 1 h and treated with 0´2% Triton X-100 solution for 10 min at room temperature.
Immunohistochemical staining
Alkaline phosphatase±antialkaline phosphatase staining was performed following established procedures. 20 Monospeci®c rabbit antiserum against human tenascin C (Biomol-Telios, Hamburg, Germany; dilution 1 : 50), human undulin 17, 21 (dilution 1 : 100) and human ®bronectin (Dako, Hamburg, Germany; dilution 1 : 800) were diluted in RPMI medium (Gibco, Berlin, Germany). The primary antibodies were incubated with the samples for 30 min and the specimens were washed thoroughly in PBS. The sections were then incubated with alkaline phosphatase-conjugated goat antirabbit immunoglobulin (Dianova, Hamburg, Germany) diluted 1 : 100 in a 1 : 1 mixture of human serum and RPMI medium for 30 min and washed as described before. The immunoreactants were visualized by incubation in a solution containing naphthol salt, hexazotized new fuchsin and levamisole, counterstained with haematoxylin and mounted in Kaiser's gelatin solution according to standard procedures. Negative controls, prepared by the same procedure but omitting the primary antibodies, were included.
Semiquanti®cation of results
The slides were viewed under a Leitz microscope. The intensity of staining in the tissue specimens was graded from (±) to ( ) and its distribution was noted. For evaluation of the ®broblast cultures, all examined in subcon¯uent state, we compared the intensity of staining and used for statistical analysis ®ve grades from 0 to 4 corresponding to negative, weak, average, strong and very strong staining. Statistical signi®cance was calculated using Student's t-test.
Results

Tissue staining
In all four samples of normal adult skin tenascin C was continuously expressed as a thin linear band associated with the basement membrane of the dermal±epidermal junction, being pronounced at the tips of the rete ridges. It was further found near the basement membrane of vessels, sebaceous glands and hair follicles (Fig. 1 ). There was no tenascin C staining in the dermal connective tissue, especially no distribution with the collagen ®bres, and there was no difference in tenascin C staining between the papillary and reticular dermis. Tenascin C staining was markedly enhanced in all four keloid specimens examined. In contrast to normal skin, it was diffusely expressed throughout the dermis and often associated with the increased number of collagen bundles which characterize keloids (Fig. 2 ). There were more such collagen deposits with tenascin C colocalization in the reticular than in the papillary dermal layer. Here, tenascin C showed a wavy pattern along the collagen ®brils and was pronounced near the basement membrane, subepidermally in the¯attened rete ridges and around the sparse vessels. There was a sharply demarcated border of tenascin C positivity with the surrounding unaffected dermal tissue (Fig. 3) .
Unlike tenascin C, the distribution of C XIV in the dermis of keloidal and normal skin was similar. A strong staining was observed in association with the collagen ®bres throughout the dermal connective tissue. In addition, there was a weak staining in the inner root sheath of the hair follicles in one of four normal skin specimens. In contrast to the restricted distribution of tenascin C in normal skin, ®bronectin was very strongly expressed in a diffuse pattern throughout the dermis, especially along collagen ®bres. The staining pattern and the distribution of ®bronectin in dermal tissue were similar in normal skin and in all keloids examined. The epidermis remained negative. In addition, there was staining of the vessel walls in normal skin and in keloid lesions.
Expression in ®broblast cultures
The cytomorphology of keloidal and normal ®broblasts was similar. The staining of keloid-derived ®broblasts with tenascin C was strong to very strong in seven of nine cultures (Fig. 4) , whereas the intensity of staining of normal ®broblasts for tenascin C (Fig. 5 ) was signi®cantly weaker (P < 0´003; Table 1 ). Pronounced immunoreactivity was located in secretory vesicles from keloidal and normal ®broblasts. There was no difference between the normal ®broblasts derived from patients with and without keloids ( Table 1 ). In accordance with the ®ndings on the tissue sections, C XIV was similarly expressed (average grade) in all keloidal and normal ®broblasts ( Table 1) . We could not ®nd any difference between normal ®broblasts derived from patients with and without keloids either in intensity or in staining pattern. Keloidal and normal ®broblasts showed a nearly homogeneous distribution of C XIV in vesicles. Fibronectin displayed an average grade staining intensity in keloidal ®broblasts, resembling the intensity of normal ®broblasts (Table 1 ). There was no difference between the normal ®broblasts derived from the patients with and without keloids. Keloidal and normal ®broblasts showed a homogeneous distribution of ®bronectin in the cell cytoplasm, whereas in some keloidal ®broblasts it was pronounced around the nucleus.
Discussion
Our immunohistochemical analysis showed a marked increase in the expression of tenascin C in keloids. It was diffusely distributed in the reticular and papillary dermis associated with collagen ®brils of affected tissue. In 52
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q 1999 British Association of Dermatologists, British Journal of Dermatology, 141, 50±56 Figure 1 . In normal skin, tenascin C is expressed as a thin linear subepidermal band associated with the basement membrane of the dermal±epidermal junction, as well as in vessel walls and appendages (original magni®cation´80). Figure 2 . In a keloid, tenascin C is diffusely expressed throughout the lesion and appears to be associated with an increased number of collagen ®bres (original magni®cation´312´5).
normal skin, tenascin C was restricted to the dermal± epidermal junction in the super®cial papillary dermis and close to the basement membrane of vessels, ducts of glands and hair follicles as observed by others. 14, 15, 22, 23 In line with our in vivo results, keloidal ®broblasts in vitro exhibited signi®cantly stronger tenascin C expression than normal ®broblasts. As the immunocytological studies were performed in passages 3±4, a major in¯uence of stimulating systemic factors can be excluded. Therefore, we suggest that keloidal ®broblasts, once stimulated, autonomously produce tenascin C in abnormally high amounts. In contrast to the ®ndings with tenascin C, we could not detect any differences either in intensity or in distribution of the staining pattern of C XIV or ®bronectin between keloids and normal skin. The strong staining for C XIV was strictly associated with densely packed collagen ®bres. In addition, no differences in intensity and staining pattern for both proteins were found between cultured keloidal and normal ®broblasts in vitro. In comparison with the marked dermal staining in vivo, the expression of C XIV in vitro seemed weaker. Our ®ndings with ®bronectin con®rm previous results in vivo and in vitro. 22, 24 This suggests that there could be a different regulation of keloidal ®broblasts to produce abnormally high amounts of tenascin C continuously, in contrast to the synthesis of C XIV and ®bronectin, although both ®bronectin and tenascin C have been reported to be upregulated by TGF-b1, 10±12 a ®brogenic cytokine reported to be increased in keloids. 10 Tenascin C is a large hexameric glycoprotein produced by mesenchymal cells such as ®broblasts or myocytes. 13, 15, 25, 26 The complete molecular sequence has been determined in humans 26 and a partial homology between tenascin C, ®bronectin and C XIV has been found. 15, 27 Tenascin C is strongly expressed in several organs during embryogenesis, being involved in epithelial±mesenchymal interactions, whereas in adult skin its expression and distribution become restricted. 16 In normal skin tenascin C is located at the dermal± epidermal junction and it surrounds blood vessels and epidermal adnexea. 14, 15 Tenascin C expression increases in conditions characterized by wound repair, 13, 16 in¯ammation 28 and malignant growth, 25, 29 and was previously suggested as a marker for malignant transformation. 30 However, it has also been found to be increased in benign lesions such as acne-induced keloids, 22 scleroderma 23,24 and hyperproliferative skin diseases. 15 In vitro studies have shown that tenascin C modulates cell proliferation, migration and adhesion by interfering with ®bronectin TENASCIN C AND KELOIDS 53
q 1999 British Association of Dermatologists, British Journal of Dermatology, 141, 50±56 Figure 3 . Tenascin C clearly labels the keloidal lesion in contrast to the surrounding unaffected dermal tissue (original magni®cation´50). Tenascin C 3´4 6 0´88 2´0 6 0´0 2´0 6 0´0 Undulin/collagen XIV 2´0 6 0´0 2´0 6 0´0 2´0 6 0´0 Fibronectin 2´0 6 0´0 2´0 6 0´0 2´0 6 0´0 0, negative; 1, weak; 2, average; 3, strong; 4, very strong.
action and by directly modulating cell differentiation and induction of differential gene expression.
25,27,31±33
Tenascin C is upregulated in response to migrating keratinocytes but is also strongly expressed in granulation tissue and at wound edges in the dermis. 13 After wound contraction is complete, tenascin C disappears more rapidly than other extracellular matrix proteins. 13 The mechanism of tenascin C induction in keloids is still unknown. Previous studies reported that TGF-b1 and interleukin 1b are potent inducers of tenascin C.
33±
35 Interestingly, TGF-b1 is increased in keloids 9 and also induces ®bronectin and collagen expression. 10, 34 Shah et al. 36 demonstrated that wounds in adult rats healed without scar formation after treatment with neutralizing antibodies to TGF-b. Although many mesenchymal cell types are able to express tenascin C, 25 dermal ®broblasts are assumed to be the main source of this protein in keloids, the expression of which may re¯ect the ongoing ®brogenic process. It is not known whether keloidal ®broblasts require a stimulating serum factor or whether they undergo further stimulation in an autocrine/paracrine manner. Our ®ndings on cultured keloidal ®broblasts suggest that keloidal ®broblasts do not require systemic stimulation to maintain their upregulated tenascin expression. On the other hand, we found in vitro that keloidal ®broblasts signi®cantly decrease their tenascin C expression after cryotherapy, in contrast to normal ®broblasts which increase their tenascin C production (data not shown). Therefore, we assume that keloidal ®broblasts are characterized by a defective feedback mechanism regulating the production of tenascin C, possibly correlated with a protracted ®brogenic activation.
Recent work showed the identity of undulin with C XIV, a large non-®brillar extracellular matrix protein that belongs to the subfamily of ®bril-associated collagens. 18, 37, 38 Its DNA sequence reveals 42% homology with regions of human ®bronectin and 33% homology with parts of tenascin C. 17, 18, 27, 37 Despite their molecular similarities, C XIV plays a divergent biological role compared with tenascin C and ®bronectin. It is abundant in¯exible connective tissues that contain large amounts of collagen ®brils. 18 In scar tissue, C XIV expression is rare and it becomes downregulated more rapidly than any other extracellular matrix protein.
17,38 C XIV was suggested therefore to play a part in the supramolecular organization of collagen ®brils to ®bres leading to¯exibility and the stability characteristic for differentiated mesenchymal tissues. 17, 18, 21 Although several mesenchymal cell lines produce C XIV, extremely low levels were found in human skin ®bro-blasts. 17 In the dermis, C XIV is found on densely packed collagen ®bres and next to vessels and appendages. 21 Prominent expression of C XIV has also been described around growing hair follicles. 39 Our ®nd-ings partially con®rm these previous results: C XIV was associated with collagen ®brils and, in addition, a weak C XIV staining was present next to hair follicles in normal dermis, but not around capillary blood vessels nor around glands.
Fibronectin, a well-known non-collagenous glycoprotein, is abundant in most interstitial connective tissues. Fibronectin is also located on collagen ®brils where it may mediate the interaction between cells and other matrix components such as collagens. It plays an important part in wound healing, promoting the development of granulation tissue. There are reports of both increased 19, 40 and normal 10,24 ®bronectin synthesis in keloidal ®broblasts.
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A.DALKOWSKI et al. In summary, our data show that despite some molecular similarities, tenascin C, C XIV and ®bronectin display characteristic and distinct distribution patterns in normal skin in correlation with their suggested functions in mesenchymal tissue. Whereas C XIV and ®bronectin preserve their distribution pattern in keloids, the pattern of tenascin C changes signi®cantly. In keloids it is expressed de novo throughout the dermis, mostly in proximity to collagen ®bres. Thus, tenascin C is an excellent marker associated with keloids, demarcating the border with unaffected skin. In addition, keloidal ®broblasts produce higher amounts of tenascin C in vitro than normal ®broblasts without stimulation by external factors, a ®nding that supports an altered feedback mechanism for tenascin C expression in keloidal ®broblasts.
